Data gathered: November 22
AI Stock Analysis - Boston Scientific (BSX)
Analysis generated October 22, 2024. Powered by Chat GPT.
Boston Scientific Corporation is a renowned medical device manufacturer specializing in minimally invasive treatments for a wide range of conditions. The company's product portfolio encompasses the cardiovascular, endoscopy, urology, and neuromodulation segments, making it a diversified player in the healthcare market. Boston Scientific is committed to innovating and bringing new, effective treatment options to the medical community, contributing to its strong market presence and growth potential.
Stock Alerts - Boston Scientific (BSX)
 |
Boston Scientific | October 21 Job postings are down by 17.6% in the last couple of days. |
|
Boston Scientific | October 14 Job postings are down by 18.3% in the last couple of days. |
|
Boston Scientific | October 10 Job postings are down by 21.8% in the last couple of days. |
|
Boston Scientific | October 9 Insider Alert: Mahoney Michael F is selling shares |
Alternative Data for Boston Scientific
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 821 | Sign up | Sign up | Sign up |
| Sentiment | 87 | Sign up | Sign up | Sign up |
| Webpage traffic | 660,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 34 | Sign up | Sign up | Sign up |
| Patents | 3,852 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 788 | Sign up | Sign up | Sign up |
| Facebook Followers | 71,387 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 5,835 | Sign up | Sign up | Sign up |
| Twitter Followers | 40,679 | Sign up | Sign up | Sign up |
| Twitter Mentions | 34 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | 44 | Sign up | Sign up | Sign up |
| ESG | 81 | Sign up | Sign up | Sign up |
| Lobbying Cost | $127,000 | Sign up | Sign up | Sign up |
| Business Outlook | 78 | Sign up | Sign up | Sign up |
| Linkedin Employees | 46,393 | Sign up | Sign up | Sign up |
| NPS | 22 | Sign up | Sign up | Sign up |
About Boston Scientific
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
| Price | $91.50 |
| Target Price | Sign up |
| Volume | 4,170,000 |
| Market Cap | $133B |
| Year Range | $66.23 - $91.5 |
| Dividend Yield | 0% |
| PE Ratio | 74.52 |
| Analyst Rating | 95% buy |
| Industry | Medical Devices |
In the news
Europe Disposable Endoscopes Market Trends Analysis Report 2025-2030, Featuring Olympus, Boston Scientific, Pentax Medical, Fujifilm, Karl Storz, Stryker, Medtronic, Ambu and SterisNovember 21 - GlobeNewswire |
|
 |
Empowered Funds LLC Raises Position in Boston Scientific Co. (NYSE:BSX)November 21 - ETF Daily News |
 |
Boston Scientific’s (BSX) Hold Rating Reiterated at Needham & Company LLCNovember 21 - ETF Daily News |
|
OneDigital Investment Advisors LLC Buys 311 Shares of Boston Scientific Co. (NYSE:BSX)November 20 - ETF Daily News |
Boston Scientific Corp. stock outperforms competitors despite losses on the dayNovember 20 - MarketWatch |
|
 |
Boston Scientific Corporation (BSX)’s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin’s PortfolioNovember 19 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 4.13B | 3.09B | 2.9B | 468M | 952M | 0.630 |
| Q2 '24 | 4.04B | 3.22B | 2.85B | 324M | 712M | 0.620 |
| Q1 '24 | 3.79B | 2.8B | 2.65B | 492M | 890M | 0.560 |
| Q4 '23 | 3.66B | 2.76B | 2.58B | 503M | 777M | 0.550 |
| Q3 '23 | 3.46B | 2.58B | 2.43B | 504M | 883M | 0.500 |
Insider Transactions View All
| Carruthers Wendy filed to sell 32,028 shares at $84.3. November 4 '24 |
| Mahoney Michael F filed to sell 1,654,181 shares at $84.3. October 8 '24 |
| Mahoney Michael F filed to sell 1,572,096 shares at $84.9. October 8 '24 |
| Fitzgerald Joseph Michael filed to sell 160,467 shares at $85. October 8 '24 |
| Carruthers Wendy filed to sell 34,748 shares at $83.9. October 2 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Michael McCaul Republican |
May 17, 24 | Sell | $15K - $50K |
| Michael McCaul Republican |
May 17, 24 | Sell | $50K - $100K |
| Michael McCaul Republican |
May 17, 24 | Sell | $100K - $250K |
Read more about Boston Scientific (BSX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Boston Scientific?
The Market Cap of Boston Scientific is $133B.
What is Boston Scientific's PE Ratio?
As of today, Boston Scientific's PE (Price to Earnings) ratio is 74.52.
What is the current stock price of Boston Scientific?
Currently, the price of one share of Boston Scientific stock is $91.50.
How can I analyze the BSX stock price chart for investment decisions?
The BSX stock price chart above provides a comprehensive visual representation of Boston Scientific's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Boston Scientific shares. Our platform offers an up-to-date BSX stock price chart, along with technical data analysis and alternative data insights.
Does BSX offer dividends to its shareholders?
As of our latest update, Boston Scientific (BSX) does not offer dividends to its shareholders. Investors interested in Boston Scientific should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Boston Scientific?
Some of the similar stocks of Boston Scientific are Edwards Lifesciences, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
.